Phase 1b, Randomized, Single-Blind, Placebo-Controlled, Study to Evaluate the Safety, Tolerability and Pharmacokinetics of MP-376 Inhalation Solution Administered for 5 Days to Chronic Bronchitis Patients.

Trial Profile

Phase 1b, Randomized, Single-Blind, Placebo-Controlled, Study to Evaluate the Safety, Tolerability and Pharmacokinetics of MP-376 Inhalation Solution Administered for 5 Days to Chronic Bronchitis Patients.

Completed
Phase of Trial: Phase I

Latest Information Update: 15 May 2015

At a glance

  • Drugs Levofloxacin (Primary)
  • Indications Bacterial infections; Chronic bronchitis
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Mpex Pharmaceuticals
  • Most Recent Events

    • 22 Dec 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 22 Dec 2008 Actual end date (Oct 2008) added as reported by ClinicalTrials.gov.
    • 30 Sep 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top